Skip to main content
. 2022 May 27;54(8):1787–1792. doi: 10.1007/s11255-022-03244-y

Table 3.

Outcome of aquablation

Parameters Baseline 3 months 6 months p value
Mean prostate size (cc) ± SD 60.8 ± 15.8 24.9 ± 10.1 24.9 ± 10.3  < 0.001#
Mean PSA (ng/ml) ± SD 12.4 ± 7.6 5.1 ± 2.9 5.7 ± 3.7  < 0.001#
Mean IIEF ± SD 16.1 ± 5.8 14.9 ± 6.4 16.6 ± 7.1 0.953#
Mean IPSS ± SD 5.8 ± 5.5 6.9 ± 8.5 0.826
Mean QoL score ± SD 1.9 ± 1.2 1.7 ± 1.1 0.192
Mean OABSS score ± SD 3.8 ± 2.7 2.8 ± 1.9 0.066
Mean Qmax (ml/s) ± SD 20.2 ± 7.6 17.6 ± 7.3 0.229
Mean RU (ml) ± SD 60.1 ± 25.2 22.3 ± 20.4  < 0.001
Retrograde ejaculation (n) 0 5 5
Mean PdetQmax (cmH2O) ± SD 41.4 ± 19.0
Mean BOOI ± SD 14.2 ± 23.0
Mean BCI ± SD 109.0 ± 30.7
Presence of detrusor overactivity (n) 4 4

SD standard deviation, PSA prostatic specific antigen, IIEF international index of erectile function, IPSS international prostate symptom score, QoL quality of life, OABSS overactive bladder symptom score, Qmax maximal voiding velocity, RU residual urine, PdetQmax maximal detrusor pressure at maximal voiding velocity, BOOI bladder outlet obstruction index, BCI bladder contractility index

#p value signifies comparison of 3-month value against pre-operative value